Health needs to be part of the conversation about investments in nature
GSK’s VP of sustainability writes exclusively for ESG Clarity on the health benefits of investing in nature
GSK’s VP of sustainability writes exclusively for ESG Clarity on the health benefits of investing in nature
Focusing on five key areas
Compelling company choice with many mid-cap names leading the way on responsible and sustainable business models
Some feel this is caused by ageism and gender discrimination
In the first part of this new series, ESG industry experts reflect on 2022 and share predictions for 2023
Pockets of opportunity exist for investors willing to cast their net wider
Tackling this ‘silent pandemic’ requires a global coordinated policy
Long-term Investors in People’s Health programme backed by L&G, Rathbone Greenbank and Federated Hermes
With increasing urbanisation, Tribe Impact Capital’s Clarke says there are opportunities for investors to support communities
Inflation Reduction Act provides certainty to sustainable investors but compromises mean fossil fuel expansion
EdenTree’s Patel says industry’s response to Covid and innovation keep it attractive to ESG investors
ESG Clarity asks experts in food, water, clean energy, social housing and healthcare where they spy challenges and opportunities